0001493152-20-012570.txt : 20200702 0001493152-20-012570.hdr.sgml : 20200702 20200702181722 ACCESSION NUMBER: 0001493152-20-012570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200702 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cross John Harry III CENTRAL INDEX KEY: 0001806763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35570 FILM NUMBER: 201011328 MAIL ADDRESS: STREET 1: C/O SONNET BIOTHERAPEUTICS HOLDINGS, INC STREET 2: 100 OVERLOOK CENTER CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001106838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 522102141 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-375-2227 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Chanticleer Holdings, Inc. DATE OF NAME CHANGE: 20050510 FORMER COMPANY: FORMER CONFORMED NAME: TULVINE SYSTEMS INC DATE OF NAME CHANGE: 20000214 4 1 ownership.xml X0306 4 2020-07-02 0 0001106838 Sonnet BioTherapeutics Holdings, Inc. SONN 0001806763 Cross John Harry III 100 OVERLOOK CENTER, SUITE 102 PRINCETON NJ 08540 0 1 0 0 Chief Financial Officer Common Stock 2020-07-02 4 A 0 78214 0.00 A 78214 D On July 2, 2020, the Reporting Person was granted 78,214 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on April 2, 2021 and 50% of the restricted stock units on April 2, 2022. /s/ John Harry Cross III 2020-07-02